Quantitative assessment of left atrial functions by speckle tracking echocardiography in hypertensive patients with and without retinopathy


Celik M., Izci S., Kivrak U., Kup A., Kahyaoglu M., Yilmaz Y., ...Daha Fazla

Journal of Clinical Ultrasound, cilt.50, sa.6, ss.759-768, 2022 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50 Sayı: 6
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1002/jcu.23248
  • Dergi Adı: Journal of Clinical Ultrasound
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Biotechnology Research Abstracts, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.759-768
  • Anahtar Kelimeler: hypertension, left atrium, retinopathy, strain
  • Uşak Üniversitesi Adresli: Hayır

Özet

Purpose: The association between hypertensive retinopathy and left atrial (LA) impairment is unknown. Accordingly, it was aimed to investigate the possible relationship between hypertensive retinopathy and LA phasic functions by means of two-dimensional speckle-tracking echocardiography (2D-STE). Methods: A total of 124 hypertensive patients and 27 control subjects were included in the study. LA reservoir strain (LAS-S), LA conduit strain (LAS-E), and LA booster strain (LAS-A) parameters were used to evaluate LA myocardial functions. Results: Hypertensive patients (with and without retinopathy) displayed an obvious reduction in the LA reservoir strain (LAS-S), and LA conduit strain (LAS-E). Moreover, further impairment in LA reservoir and conduit strain was found in patients with hypertensive retinopathy than in the isolated hypertensive patients. There were no significant differences in LA booster strain (LAS-A) among the three groups. Impaired LAS-S (OR: 0.764, CI: 0.657–0.888, and p < 0.001), LAS-E (OR: 0.754, CI: 0.634–0.897, and p = 0.001), and hypertension (HT) duration (OR: 2.345, CI: 1.568–3.507, and p < 0.001) were shown to be independent predictors of hypertensive retinopathy. Conclusion: Impaired LA reservoir and conduit strain may be used to predict hypertensive patients at higher risk of developing hypertensive retinopathy, and to determine which patients should be followed more closely for hypertensive retinopathy.